Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

M. J. Georgetson; J. C. Yarze; A. T. Lalos; G. F. Webster; P. Martin

Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

M. J. Georgetson, J. C. Yarze, A. T. Lalos, G. F. Webster, P. Martin

Research output: Contribution to journal › Article › peer-review

Abstract

Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

Original language	English (US)
Pages (from-to)	1756-1758
Number of pages	3
Journal	American Journal of Gastroenterology
Volume	88
Issue number	10
State	Published - Jan 1 1993
Externally published	Yes

ASJC Scopus subject areas

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0624cca5a16d477dbd7afb0ad7e4a73e,

title = "Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis",

abstract = "Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.",

author = "Georgetson, {M. J.} and Yarze, {J. C.} and Lalos, {A. T.} and Webster, {G. F.} and P. Martin",

year = "1993",

month = jan,

day = "1",

language = "English (US)",

volume = "88",

pages = "1756--1758",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

AU - Georgetson, M. J.

AU - Yarze, J. C.

AU - Lalos, A. T.

AU - Webster, G. F.

AU - Martin, P.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

AB - Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0027370219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027370219&partnerID=8YFLogxK

M3 - Article

C2 - 8213720

AN - SCOPUS:0027370219

VL - 88

SP - 1756

EP - 1758

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -

Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this